Competition office fines Vitabalans for misleading advertising
Hungary's Competition Office (GVH) today announced it had fined Vitabalans Kft. and Vitabalans Oy HUF 10.8 mln due to misleading advertising, which made unsubstantiated claims regarding its Lacto Seven and Lopacut 2 mg products during a period of more than two years beginning in the summer of 2011, Hungarian news agency MTI reported today.
According to the competition office, the companies also failed to clearly identify in advertisements that Lopacut 2 mg is a medicine.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.